Skip to main content
. 2019 Jul 16;38(36):6382–6398. doi: 10.1038/s41388-019-0890-7

Fig. 1.

Fig. 1

Correlations between PERK and FOXO3 expression and activity in MCF-7 and MCF-7-EpiR cells in response to epirubicin. a The epirubicin-sensitive MCF-7 and -resistant MCF-7-EpiR cells were either left untreated or treated with 1 µM epirubicin for the times shown. Whole-cell protein lysates were then analysed by western blotting using the antibodies against the proteins indicated. Molecular weight markers are shown. The protein expression levels of P-FOXO3 (T32) (95 kDa), FOXO3 (95 kDa), FOXM1 (110 kDa) and ER stress molecules, including P-PERK (T981) (140 kDa), PERK (140 kDa), P-eIF2a (S51) (38 kDa), eIF2a (38 kDa), P-AKT (S473) (60 kDa), P-AKT (T308) (60 kDa), AKT (60 kDa), p27Kip1 (27 kDa) and β-Tubulin (55 kDa) were investigated. b FOXO3, PERK, FOXM1, p27Kip1 mRNA expression after treatment with epirubicin as determined by RT-qPCR. Representative RNA expression profiles of at least three independent experiments. Three technical repeats were conducted in one experiment, and the data were normalised to L19 and displayed as means ± S.E.M. The expression trends of mRNA species between MCF-7 and MCF-7-EpiR cells are compared using two-way ANOVA (Significant ***p < 0.001, for all mRNA species, respectively)